Concepedia

Maren Lübke

ML

7

Publications

1K

Citations

7

H-Index

2018

Active since

Affiliations

Deutschen Konsortium für Translationale Krebsforschung(Current)

University of Tübingen

University Children's Hospital Tübingen

Max Planck Institute for Developmental Biology

German Cancer Research Center

Maren Lübke is an author at Deutschen Konsortium für Translationale Krebsforschung specializing in immunology, medicine, and autoimmunity.

ORCID

Top concepts

Publications per year

2018–2021

7

Publications

7

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann et al. · Nature Immunology · 2020 · 630 citations

, , +2

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

Ana Marcu, Leon Bichmann, Lèon Kuchenbecker et al. · Journal for ImmunoTherapy of Cancer · 2021 · 231 citations · Full text

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

Tatjana Bilich, Annika Nelde, Leon Bichmann et al. · Blood · 2018 · 75 citations · Full text

SARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann et al. · 2020 · 36 citations · Full text

, , +15

The HLA Ligand Atlas - A resource of natural HLA ligands presented on benign tissues

Ana Marcu, Leon Bichmann, Lèon Kuchenbecker et al. · 2019 · 34 citations · Full text

, , +25

Rows per page

1–5 of 7